Arcus biosciences to participate in upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences, inc. (nyse:rcus), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming 2021 virtual investor conferences: 10th annual svb leerink global healthcare conference, friday, february 26 at 12:00 pm et cowen 41st annual health care conference, tuesday, march 2 at 11:10 am et barclays global healthcare conference, wednesday, march 10 at 1
RCUS Ratings Summary
RCUS Quant Ranking